Marcus Autism Center is a not-for-profit organization focused on the diagnosis and treatment of children with autism and related disorders. Since its establishment in 2009, it has had a significant impact, treating around 5,000 children annually and positively affecting over 10,000 children beyond its facilities. The center, headquartered in the United States, operates as a subsidiary of Children’s Healthcare of Atlanta and collaborates with the Emory University School of Medicine.
What sets Marcus Autism Center apart is its ability to provide crucial services and conduct pioneering research, made possible with substantial philanthropic backing and funding from local and state governments. The dedicated staff, composed of highly trained pediatric professionals, is reinforced by research grants from the National Institutes of Health (NIH) and other esteemed organizations, positioning the center as one of the three NIH Autism Centers of Excellence.
With a focus on the health care industry, Marcus Autism Center’s commitment to improving the lives of children with autism makes it an attractive prospect for potential venture capital involvement. Although specific details about the latest investment and investors are not available, the center's impactful mission and significant contributions within the field of autism treatment make it a compelling opportunity for those considering investment within the health care sector.
There is no investment information
No recent news or press coverage available for Marcus Autism Center.